Literature DB >> 26040553

Oncologic outcome after local recurrence of chondrosarcoma: Analysis of prognostic factors.

Han-Soo Kim1, Srimanth S Bindiganavile1, Ilkyu Han1.   

Abstract

BACKGROUND: Literature on outcome after local recurrence (LR) in chondrosarcoma is scarce and better appreciation of prognostic factors is needed.
OBJECTIVES: (1) To evaluate post-LR oncologic outcomes of disease-specific survival and subsequent LR and (2) to identify prognostic factors for post-LR oncologic outcomes. PATIENTS AND METHODS: Review of 28 patients with locally recurrent chondrosarcoma from the original cohort of 150 patients, who were treated surgically with or without adjuvants between 1982 and 2011, was performed. Mean age was 46 years (range, 21-73) which included 20 males and 8 females with mean follow up of 8.4 ± 7.5 years (range, 1.2-31.0).
RESULTS: Post-LR survival at 5 years was 58.6 ± 10.3%. Age greater than 50 years (P = 0.011) and LR occurring within 1 year of primary surgery (P = 0.011) independently predicted poor survival. Seven patients suffered subsequent LR, which was significantly affected by surgical margin for LR (P = 0.038).
CONCLUSION: Long-term survival of locally recurrent chondrosarcoma is achievable in a substantial number of patients. Older age at onset of LR and shorter interval from primary surgery to LR identifies high risk patients for poor post-LR survival while, wide surgical margins at LR surgery reduces the risk of subsequent LR.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  axial; chondrosarcoma; grade; local recurrence; metastasis

Mesh:

Year:  2015        PMID: 26040553     DOI: 10.1002/jso.23925

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database.

Authors:  Jun Zhang; Zhenyu Pan; Fanfan Zhao; Xiaojie Feng; Yuanchi Huang; Chuanyu Hu; Yuanjie Li; Jun Lyu
Journal:  Int J Clin Oncol       Date:  2019-06-26       Impact factor: 3.402

2.  Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group.

Authors:  Tomoki Nakamura; Jun Sugaya; Norifumi Naka; Hiroshi Kobayashi; Tomotake Okuma; Toshiyuki Kunisada; Kunihiro Asanuma; Hedetatsu Outani; Shunji Nishimura; Hiroyuki Kawashima; Toru Akiyama; Taketoshi Yasuda; Shinji Miwa; Akihiro Sudo; Takafumi Ueda
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

Review 3.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

4.  Clinical Statistical Analysis with Comparison between Pelvic and Non-pelvic Chondrosarcoma.

Authors:  Sayed Abdulla Jami; Shi Jiandang; Brotendu Shekhar Roy; Zhanwen Zhou; Liu Chang Hao
Journal:  Oman Med J       Date:  2021-05-31

5.  TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.

Authors:  Xiaolong Xu; Xiaodong Tang; Wei Guo; Kang Yang; Tingting Ren
Journal:  Tumour Biol       Date:  2016-08-13

6.  Risk Factors for Incidence and Prognosis in Chondrosarcoma Patients with Pulmonary Metastasis at Initial Diagnosis.

Authors:  Minh Tien Nguyen; Yun-Qi Jiang; Xi-Lei Li; Jian Dong
Journal:  Med Sci Monit       Date:  2019-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.